Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_assertion type Assertion NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_head.
- NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_provenance.
- NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_assertion evidence source_evidence_literature NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_provenance.
- NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_assertion SIO_000772 23733802 NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_provenance.
- NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_assertion wasDerivedFrom befree-20150227 NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_provenance.
- NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_assertion wasGeneratedBy ECO_0000203 NP411716.RAT6CTZ9RGMW3gBP6OYl3Wb65lC7Ihf3_PzgxXrB2dXJE130_provenance.